Two Sigma Securities, LLC Clearside Biomedical, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.08 - $1.58 $3,461 - $5,063	-3,205 Reduced 14.56%	18,802 $24,000
Q1 2024 May 15, 2024	BUY	$1.2 - $2.02 $26,408 - $44,454	22,007 New	22,007 $33,000
Q2 2023 Aug 14, 2023	BUY	$0.97 - $1.48 $15,247 - $23,264	15,719 New	15,719 $17,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $11,072 - $16,608	11,072 New	11,072 $12,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $28,147 - $53,913	-21,652 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.35 - $2.88 $29,230 - $62,357	21,652 New	21,652 $50,000
Q3 2019 Nov 14, 2019	SELL	$0.59 - $1.32 $9,732 - $21,774	-16,496 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.97 - $1.42 $16,001 - $23,424	16,496 New	16,496 $16,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.